China Surpasses US in R&D Spending
Analysis based on 6 articles · First reported Apr 24, 2026 · Last updated Apr 28, 2026
The shift in scientific and technological leadership from the United States to China could lead to a long-term decline in the United States' economic growth and innovation capacity. Investors may re-evaluate investment opportunities in both nations, potentially favoring China's growing tech and research sectors while being cautious about the United States' future competitiveness.
China has reached a significant milestone in scientific and technological research, with its investment in R&D now matching and, by purchasing power, surpassing that of the United States, according to a March 2026 report by the OECD. This marks a structural shift in global scientific leadership, as China has also surpassed the United States in highly-cited papers, total scientific publications, and patent applications. The United States' decline is attributed to a long-term divestment from public R&D funding, restrictive policies on scientific exchange, and budget cuts under the second Trump administration, which threaten to further erode its scientific infrastructure and ability to benefit from global scientific advancements.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard